Get the Stockscreener App
92.10
1.15%
-1.07
After Hours:
92.09
-0.010
-0.01%
Iradimed Corp stock is traded at $92.10, with a volume of 140.47K.
It is down -1.15% in the last 24 hours and up +2.17% over the past month.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
See More
Previous Close:
$93.17
Open:
$93.01
24h Volume:
140.47K
Relative Volume:
1.40
Market Cap:
$1.18B
Revenue:
$86.28M
Net Income/Loss:
$23.61M
P/E Ratio:
50.17
EPS:
1.8359
Net Cash Flow:
$23.97M
1W Performance:
+6.55%
1M Performance:
+2.17%
6M Performance:
+2.88%
1Y Performance:
+76.17%
1-Day Range:
$91.37
$95.47
1-Week Range:
$85.40
$95.47
52-Week Range:
$50.88
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
92.10 | 1.19B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
IRMD Stock Chart | IRADIMED CORP (NASDAQ:IRMD) - ChartMill
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Earnings Surprise Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
A Look At IRADIMED (IRMD) Valuation After Q1 2026 Growth, New Pump Rollout And Dividend - Sahm
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
IRMD (iRadimed Corporation) tops Q1 2026 EPS estimates by 8 percent, shares rise 4.45 percent in today’s session.Open Stock Signal Network - Newser
iRadimed (NASDAQ:IRMD) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
IRadimed Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
iRadimed Corp (IRMD) Q1 2026 Earnings Call Highlights: Strong Re - GuruFocus
Why Iradimed Stock Topped the Market Today - Yahoo Finance
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Te - GuruFocus
iRadimed Corporation (NASDAQ:IRMD) Plans Quarterly Dividend of $0.20 - MarketBeat
IRADIMED CORPORATION Files Form 8-K with SEC for May 2026 – Company Information, Address, and Stock Exchange Details - Minichart
IRADIMED CORP 1Q 2026: Revenue $21.98M, EPS $0.45— 10-Q Summary - TradingView
IRADIMED (NASDAQ: IRMD) Q1 2026 revenue rises 13% to $22M - Stock Titan
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseShould You Buy? - MarketBeat
iRadimed Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Iradimed Co beats Q1 2026 expectations, stock dips - Investing.com
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
IRadimed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Iradimed reports Q1 2026 revenue $22.0M, GAAP EPS $0.45; declares $0.20 quarterly dividend - TradingView
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q2 2026 Earnings Guidance - MarketBeat
IRADIMED ($IRMD) Releases Q1 2026 Earnings - Quiver Quantitative
IRADIMED (NASDAQ: IRMD) Q1 growth, dividend and 2026 outlook - Stock Titan
IRadimed: Q1 Earnings Snapshot - WKYC
MRI device maker IRADIMED launches new pump as Q1 sales climb 13% - Stock Titan
Roger Susi Sells 3,750 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Executive pay and director votes at Iradimed (NASDAQ: IRMD) 2026 meeting - Stock Titan
Iradimed CEO Susi’s trust sells $657,709 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Susi’s trust sells $657,709 in company stock - Investing.com
How The Evolving Story For IRADIMED (IRMD) Is Shaping Analyst Targets And Fair Value - Yahoo Finance
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
IRADIMED to post Q1 results before the bell May 1, call at 11 a.m. ET - Stock Titan
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):